Patent Yard Sign in
Expired Australian patentAustralia

Substituted imides as TNF inhibitors

AU 1996042463 · Applicant: Celgene Corporation

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 20, 1995 and granted December 16, 1999. An Australian standard patent lasts 20 years from its date of patent, which is at most a year after this filing, so its term ended by November 20, 2016.
  • A pharmaceutical extension adds at most five years, so even that would have ended by November 20, 2021.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 20, 1995
GrantedDecember 16, 1999
Term ended byNovember 20, 2016
Application numberAU 1996042463
Classification (IPC)A61K31/4035 +2 more

Timeline

Timeline From IP Australia dates

1996199920022005200820112014Application filedNov 20, 1995Patent grantedDec 16, 1999Term ended byNov 20, 2016

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.